Coiante Scott M 4
4 · LEXICON PHARMACEUTICALS, INC. · Filed Jan 2, 2025
Insider Transaction Report
Form 4
Coiante Scott M
SVP, Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-01-02+230,000→ 230,000 totalExercise: $0.74Exp: 2035-01-02→ Common Stock (230,000 underlying)
Footnotes (1)
- [F1]Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter.